Market Research Blog – Page 104 – Just another WordPress site

Global Mammography Industry is expected to grow at a 10.1% CAGR to reach US$4,899.7 Million by 2033 | FMI Study

The Global Mammography Industry is on track for a significant surge, driven by rising awareness and advancements in early breast cancer detection. According to a recent study by Future Market Insights (FMI), the market is projected to reach US$4.9 billion by 2033, reflecting a remarkable Compound Annual Growth Rate (CAGR) of 10.1% from 2023 to 2033. This growth follows a solid foundation, with the market valued at an estimated US$1.74 billion in 2022 and reaching US$1.88 billion in 2023.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-9040

The rising prevalence of breast cancer around the world, combined with growing awareness about the benefits of screening and early detection of breast cancer, is driving the Global Mammography Industry forward. It is one of the most common types of cancer in females around the world.

Several studies have found that the risk of breast cancer increases with age and is more common in women over the age of 40. Because of this, medical institutes and organizations such as the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN) have recommended annual mammography screening for women beginning at the age of 40. This will continue to be a driving force in market growth in the future.

For the early detection of breast cancer, various mammography solutions or types, such as breast tomosynthesis, film screen systems, and X-rays, are used. However, film screen systems, also known as screen-film mammography, continue to be the gold standard for detecting breast cancer.

Various government and non-government organizations are investing heavily in increasing breast cancer screening and, as a result, lowering the overall burden. This will continue to be a tailwind for market growth in the future. Furthermore, the presence of favorable reimbursement policies in many developed regions is positively impacting the growth of the mammography market.

Which Factors Determine the Growth of the Global Mammography Industry?

Some of the major factors driving the Global Mammography Industry are the rapid increase in the number of breast cancer cases, technological advancements in breast imaging techniques, and increased initiatives and investments by government and private organizations for breast cancer monitoring campaigns.

Mammography has emerged as one of the most advanced techniques for detecting breast cancer in its early stages. It has significantly aided medical organizations in reducing the global burden of breast cancer.

The rising incidence of breast cancer is driving the growth of the mammography market. According to the World Health Organization (WHO), an estimated 2.3 million women in the world will be diagnosed with breast cancer by 2020. Early detection of breast cancer is required for proper treatment to begin, increasing the chances of survival. As a result, the mammography technique is increasingly being used in healthcare facilities.

Similarly, factors such as rising cases of hormonal imbalance, an aging population, and increased awareness among women about breast cancer, diagnosis, and treatment will continue to drive mammography system sales in the future.

In addition to this, technological advancements in mammography systems such as the development of 3-D imaging solutions (breast tomosynthesis) coupled with an increase in the number of hospitals, diagnostic centers, and specialty centers are projected to further boost the growth of the mammography market in the future.

Grab Your Discount Now Before It’s Gone!
https://www.futuremarketinsights.com/request-discount/rep-gb-9040

What are the Challenges Faced by the Mammography Industry?

Despite the growing popularity of mammography for the detection of breast cancer, several challenges are stifling market growth. Some of these factors include the risk of radiation exposure, high capital investment, and a lack of awareness about mammography systems in some developing and underdeveloped countries.

Will North America Retain its Dominant Position in the Global Mammography Industry?

North America is expected to maintain its dominance in the Global Mammography Industry as the prevalence of breast cancer rises, people become more aware of the importance of diagnostic screening for initiating early treatment, and government and private organizations increase their spending on research and development.

Because of rising breast cancer cases, the availability of advanced diagnostic solutions, and favorable government support, the United States remains the most profitable market for mammography in North America. According to the American Cancer Society, there will be approximately 287,850 new cases of invasive breast cancer diagnosed in the United States in 2022. During the forecast period, the Global Mammography Industry will continue to grow in North America.

What is the Growth Projection for the Asia Pacific Market?

According to Future Market Insights, the Asia Pacific Global Mammography Industry is expected to grow rapidly during the forecast period, owing to increased adoption of mammography systems, increased government investments and initiatives to combat breast cancer burden, and rapid development of healthcare infrastructure in countries such as China and India.

Growing awareness about breast cancer, its diagnosis, and the availability of alternative treatments is driving the growth of the mammography market in Asia Pacific countries such as India and China. People are increasingly turning to these techniques for early detection of breast cancer. Once detected, timely treatment can be administered, increasing the chances of survival and lowering the economic burden.

Moreover, governments across these countries are taking various initiatives to reduce the rising burden of breast cancer cases. This is creating a conducive environment for the growth of the Global Mammography Industry in the region.

Global Mammography Industry Competition

Some of the key participants present in the Global Mammography Industry include Allengers Medical Systems Limited, FUJIFILM Holdings America Corporation, Hologic, Inc., PLANMED OY, Konica Minolta, GENERAL ELECTRIC, Inc., Siemens Healthcare Private Limited, Carestream Health, GE Healthcare, Koninklijke Philips N.V., and BET Medical.

These leading players are continuously innovating to develop novel diagnostic products with enhanced features and minimum side effects. Besides this, they are adopting growth strategies such as partnerships, acquisitions, collaborations, spending on awareness campaigns etc. to gain a competitive edge in the market.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-9040

Key Segments Profiled in the Global Mammography Industry Survey

By Product Type:

Breast Tomosynthesis
Film Screen Systems
X-Ray
Others

By Technology Type:

Digital Mammography
Analog Mammography
3-D Mammography
2-D Mammography

By End Use:

Hospitals
Special Clinics
Diagnosis Centers
Ambulatory Surgical Centers
Educational & Research Institutes

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market Set to Flourish, Expected to Reach at a CAGR of 9.5%

The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders market is poised for significant growth, reaching an estimated US$19.52 billion by 2033. This represents a compound annual growth rate (CAGR) of 9.5% from a market size of US$7.88 billion in 2023, according to industry projections.

The growth is attributed to the rising prevalence of neuromuscular disorders and the increasing demand for effective treatment options. Neuromuscular disorders are a group of conditions that affect the nerves and muscles, causing weakness, fatigue, and difficulty with movement. Gene therapies offer a promising approach to treating these conditions by addressing the underlying genetic cause.

Diagnostic tests and physical examinations are used in the diagnosis of neuromuscular disorders. An evaluation of the patient’s entire medical history is conducted by a doctor in order to ascertain whether any family members have ever experienced symptoms of neuromuscular problems.

Explore With Your Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16249

The global nucleic acid and gene therapies in neuromuscular disorders market is driven by major factors such as rise in government initiatives to ensure early diagnosis, an increase in awareness about genetic disorders, an upsurge in research and development activities, and improvement in healthcare infrastructure.

Factors including the expanding investments by key market players, a strong product portfolio, as well as a high prevalence of target diseases and interest in innovative and new therapy are expected to escalate the market growth in the forthcoming years. In addition, the increased investment in research and development by government and private organizations are anticipated to further create lucrative avenues for the market growth over the analysis period.

In recent years, the rapid technological advancements in cellular and molecular biology in genomics research are other factors that have been contributing greatly to the market growth. The academicians, researchers, and in-house researchers of major market companies with significant funding have all played critical roles.

The frequency of cardiovascular diseases is increasing in many industrialized countries, and there is a growing need to cure these diseases in less time, resulting in players investing extensively in research and development of highly effective and innovative therapeutics such as gene therapy. The prevalence of rare diseases such as cardiovascular and cancer diseases will have positive impact on the demand for gene therapy applications. This in turn is likely to expand the market growth in the near future.

Obtain Methodology Information:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16249

Currently, only a few market players are dominating the market growth, and are significantly contributing to the market’s expansion. The core members who are working on item dispatching and other important coordinated activities to strengthen their market reach globally. In order to increase their cancer gene therapy research and product portfolio, local and small market players are increasingly partnering and developing alliances with large market players.

Key Takeaways from the Market Study

Global Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market was valued at US$ 7.19 Bn by 2022-end
From 2018 to 2022, the market demand expanded at a CAGR of 5%
By Therapy, the Spinal Muscular Atrophy segment of the market constitutes the bulk of the market with a market share of 46%
By Application, the Hospitals segment dominates the market with a share of 45%
From 2023 to 2033, Nucleic Acid And Gene Therapies in Neuromuscular Disorders sales are expected to flourish at a CAGR of 5%.
By 2033, the market value of Nucleic Acid And Gene Therapies in Neuromuscular Disorders is expected to reach US$ 52 Bn.

Increasing research and development, as well as the growing prevalence of neuromuscular disease are the major factors that are expected to accelerate the growth of the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market during the forecast period, remarks an FMI analyst.

Competitive Landscape

Prominent players in the Nucleic Acid And Gene Therapies In Neuromuscular Disorders market are Pfizer, Inc., F. Hoffmann-La Roche Ltd., UCB Pharma, Biogen, Astellas Pharma, Inc., Novartis AG, Abbott Laboratories, Inc., and Sanofi, among others.

Recent Developments:

In May 2021, Biogen and Capsigen collaborated to discover as well as develop novel AAV Capsids with enhanced properties to facilitate the development of new gene therapies for targeted CNS and Neuromuscular Disorders. Capsigen’s screening technology is designed to produce dose optimized, fit for purpose vectors that may have applicability across Biogen’s gene therapy pipeline. Capsigen received a $15 million upfront payment and is eligible to receive potential research, development and commercial milestone payments.
In June 2019, Vertex Pharmaceuticals Incorporated announced the enhancement of its gene editing capabilities to develop novel therapies for Duchenne Muscular Dystrophy (DMD) and Myotonic Dystrophy Type 1 (DM1) by expanding its collaboration with CRISPR Therapeutics and acquiring Exonics Therapeutics. Vertex and CRISPR Therapeutics had expanded their collaboration and entered into an exclusive licensing agreement to discover and develop gene editing therapies for the treatment of DMD and DM1.

Know More About What the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market Repost Covers

Future Market Insights offers an unbiased analysis of the global Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market, providing historical data for 2018-2022 and forecast statistics from 2023-2033. To understand opportunities in the Nucleic Acid And Gene Therapies in Neuromuscular Disorders Market, the market is segmented on the basis of disorder, therapy, and application, across five major regions.

Key Segments Covered in the Nucleic Acid And Gene Therapies In Neuromuscular Disorders Industry Analysis

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Disorder:

Motor Neuron Diseases
Neuropathies
Neuromuscular Junction Disorders
Myopathies including Muscular Dystrophies

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Therapy:

AAV Gene Therapy
Postnatal Gene Therapy
Spinal Muscular Atrophy

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Application

Hospitals
Specialty Clinics
Ambulatory Surgery Centers

Nucleic Acid And Gene Therapies In Neuromuscular Disorders Market by Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Explore In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/16249

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Multi-channel Remote ECG Monitors Industry is projected to develop at a 4.8% CAGR and reach US$ 313.7 Million by 2033 | FMI

The Global Multi-channel Remote ECG Monitors Industry is on a promising growth trajectory, according to a new report by Future Market Insights (FMI). The market, valued at an estimated US$187.8 million in 2022, is projected to reach US$196.2 million by 2023. However, the most significant growth is anticipated in the coming decade, with sales of multi-channel remote ECG monitors expected to climb at a robust Compound Annual Growth Rate (CAGR) of 4.8%. This upward trend is poised to push the market valuation to a staggering US$313.7 million by 2033.

The surge in demand for multi-channel remote ECG monitors can be attributed to the industry’s unwavering commitment to the rapid identification of abnormalities, ensuring timely and effective treatment. Noteworthy industry players are strategically focusing on expanding and diversifying their market share, while simultaneously attracting new clients by seizing available business prospects.

In a world grappling with the global burden of heart disease, a leading cause of increased mortality and physical impairment, the significance of timely detection and intervention cannot be overstated. Researchers, in their pursuit of revolutionary healthcare solutions, have identified the multi-channel remote ECG monitor as a game-changer.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5567

Multi-channel Remote ECG Monitors’ major job is to detect electrical impulses and display them on a monitoring device screen, with accuracy and speed being critical variables. The recently announced multi-channel remote ECG monitor received FDA authorization, which has had a considerable economic influence on the market for ECG monitor devices. This technology represents an important milestone in wireless cardiac monitoring and can potentially improve patient care by giving healthcare professionals and patients continual information.

As the rate of cardiac death among both young and old individuals rises, so will the demand for Multi-channel Remote ECG Monitors. These technologies can lower the chances of cardiac arrest by offering remote monitoring, wireless functionality, and a faster procedure. Traditional ECG monitors with wires and nodes that require lengthy hospital stays are being phased out in favour of modern Multi-channel Remote ECG Monitors, which are expected to dominate the market throughout the forecast period.

Multi-channel Remote ECG Monitors are dependable, wireless, and suitable for detecting atrial fibrillation and other arrhythmias that are frequently quiet and intermittent. According to the American Heart Association, heart disease and stroke cause around 17.3 million deaths in the United States each year, with this figure anticipated to climb to 23.6 million by 2030. The multi-channel remote ECG monitor is intended to help busy clinics and healthcare professionals with their everyday work, and it is affordable in both developing and developed countries.

Global Multi-channel Remote ECG Monitors Industry: Drivers and Restraint

According to the Centres for Disease Control and Prevention, between 2.7 million and 6.1 million persons in the United States have Atrial Fibrillation, with this figure expected to rise as the population ages. In the United States, the annual cost of atrial fibrillation is estimated to be $6 billion. The Global Multi-channel Remote ECG Monitors Industry is predicted to develop as the prevalence of cardiovascular illnesses rises, along with technical advancements in ECG monitoring devices and increased awareness of lifestyle diseases.

Improving global population health, utilizing information technologies in medicine, and manufacturing medical devices are expected to drive growth in the Global Multi-channel Remote ECG Monitors Industry. However, challenges such as reimbursement scenarios, the availability of alternative ECG monitors, and other factors may hinder market growth.

Ask An Analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-5567

Global Multi-channel Remote ECG Monitors Industry: Overview

Companies are focusing on collaboration, acquisition, and merger by various manufacturers to expand their technology to gain insight in the diagnosis and monitoring of the cardiac patient. Rising incidences of cardiovascular diseases, government funding to initiate research and development in the ECG monitoring devices market, and rising incidences of cardiovascular diseases are all contributing to the growth of multichannel remote ECG monitors.

Global Multi-channel Remote ECG Monitors Industry: Key Market Participants

The key players in the Global Multi-channel Remote ECG Monitors Industry are Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Nihon Kohden Corporation, Omron Corporation, OSI Systems Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Welch Allyn, Smiths Medical, Abbott, Boston Scientific Corporation, Dräger Medical, GE Healthcare, Honeywell, Johnson & Johnson, LifeWatch, Medtronic, Masimo, Vitls, Inc., CareValidate, Biotronik, American Telecare, ZOLL Medical Corporation, Minerva Imaging, Boston Scientific Corporation, Baylis Medical Company, Altaris Capital Partners LLC., Itamar Medical Ltd., Asahi Kasei Company, BK Medical, Peerbridge Health, Omron, Alivecor, VivaLnk, etc.

Global Multi-channel Remote ECG Monitors Industry Key Segments

By Type:

Wired Multi-Channel Remote ECG Monitor
Wireless Multi-Channel Remote ECG Monitor

By Application:

Hospitals
Clinics
Lifestyle

Click Here To Buy Your Full Report!
https://www.futuremarketinsights.com/checkout/5567

Author

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Small Satellite Market Soars with 15.3% CAGR, Projected to Reach US$ 55.9 Billion by 2033

The small satellite market is expected to thrive at a strong CAGR of 15.3% during the forecast period. The market is anticipated to cross a market size of US$ 55.9 billion by 2033, while it holds a revenue of US$ 13.5 billion in 2023.

The expanding space exploration programs around the world have become an important element in the space race. Thus, the applications of small satellites become important
Small satellite market thrives on factors such as new technology, research and development programs, and private companies and startups investing in outer space exploration.
Countries and their defence programs are also adopting a huge number of small satellites while also building constellations for observation and surveillance.

Request a Sample Copy of the Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-3298

Different types of carriers and launch pads have also been built according to the reusable rockets and satellites. The latest addition to sustainable technology is the use of reusable and biodegradable materials while building satellites to minimize space waste.
Emerging economies like India and China have started building and advancing their space exploration programs with the help of commercial rides, payload carriers, and satellite carriers. Small startups are also helping organizations like ISRO and DRDO to create sustainable solutions for space programs.

Key Points

The US market for small satellite holds the biggest market share and is likely to cross the anticipated values of US$ 7.2 Bn by 2033 with a CAGR of 14.8%. The growth rate is rising for the US market as the market flourished from a lower CAGR of 11.0% between 2017 and 2022.
The Indian small satellite market thrives at the highest CAGR of 18.2% during the forecast period, while like revenue of US$ 701.1 million by 2033. The regional market was at a lower CAGR of 13.5% during the previous forecast period.
The small satellite market outlook states that the nanosatellites segment continues to lead the satellite type category with a CAGR of 15.9% between 2023 and 2033. The growth is owed to the easy implementation, effective use and cheaper cost.
Based on end-user type, the defence segment thrives at a CAGR of 15.3% between 2023 and 2033. This is due to the increased use of surveillance for enhanced security of the defense personnel.

Festive Offer! Get Customized Report at 40% Discount: https://www.futuremarketinsights.com/customization-available/rep-gb-3298

Competitive Landscape

Major players in small satellite market focus on experimenting with the size by using lighter materials in the production of these small satellites. Brands make satellites with a weight of 500 kg to increase performance and save rocket fuel too. Key players in the market are Orbital ATK, Inc., Ball Corporation, Airbus, Boeing, Lockheed Martin Corporation, Israel Aerospace Industries Ltd., QinetiQ, ISIS- Innovative Solutions In Space B.V., OHB SE, Surrey Satellite Technology Ltd., Planet Labs Inc.

For instance:

Lockheed Martin Corporation launched its advanced satellite series which has LM 50, offering compact size, optimized design, and efficient packaging while its mission life lies between three months to five years.
Ball Corporation has introduced BCP 100, which is a small satellite and offers a rapid and frequent response to meet mission requirements. Another satellite is BCP 300 that is applied for the demonstration mission for tests and other technological experiments.

Key Segments

By Satellite Type:

Micro-Satellite
Mini-Satellite
Nano-Satellite
Pico-Satellites

By End User:

Civil
Commercial
Defense

By Region:

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)

For any queries or concerns: https://www.futuremarketinsights.com/ask-question/rep-gb-3298

Author:

Sudip Saha is the managing director and co-founder at Future Market Insights, an award-winning market research and consulting firm. Sudip is committed to shaping the market research industry with credible solutions and constantly makes a buzz in the media with his thought leadership. His vast experience in market research and project management a consumer electronics will likely remain the leading end-use sector cross verticals in APAC, EMEA, and the Americas reflects his growth-oriented approach to clients.

He is a strong believer and proponent of innovation-based solutions, emphasizing customized solutions to meet one client’s requirements at a time. His foresightedness and visionary approach recently got him recognized as the ‘Global Icon in Business Consulting’ at the ET Inspiring Leaders Awards 2022.

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Focused Ultrasound System Industry to Expand at Incredible Rate, Reaching Over US$ 13.2 Billion at a 6.1% CAGR in 2033 | FMI

The Global Focused Ultrasound System Industry is on a trajectory for significant growth, according to projections from Future Market Insights (FMI). The market is estimated to reach a staggering US$13.28 billion by the end of this decade, reflecting a disruptive compound annual growth rate (CAGR) of 6.1% from 2023 to 2033. This surge comes on the heels of a strong showing in 2023, with the market valued at US$7.35 billion, up from US$7.01 billion in 2022.

Global Focused Ultrasound System Industry: Overview

The Global Focused Ultrasound System Industry is majorly driven by increasing patient compliance with non-invasive treatment procedures. By technology, the focused ultrasound system market is expected to be dominated by the MR-guided focused ultrasound system segment due to its high efficiency as compared to others. By application, the Global Focused Ultrasound System Industry is expected to be dominated by the oncology segment due to a high number of procedures. By end users, the Global Focused Ultrasound System Industry is expected to be dominated by the hospital segment due to high patient footfall for the treatment.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-8582

Global Focused Ultrasound System Industry: Drivers and Restraints:

The Global Focused Ultrasound System Industry is majorly driven by the non-invasive and site-specific nature of the treatment of various diseases without affecting the surrounding tissues. The treatment with a focused ultrasound system requires around 2 to 4 hours only without the need for analgesia which in turn further increases patient compliance and ease of treatment procedure fueling the growth of the market.

The reduced time or no time of inpatient stay after treatment with a focused ultrasound system further decreases the economic burden of treatment and increases the traction of market growth. By coupling the ultrasound with an MRI scanner healthcare professionals can actually see the real-time visuals of tissues to be treated hence improving preciseness as well as therapeutic outcome. An increasing number of clinical trials and increasing spending on research and development by the focused ultrasound system manufacturing companies are further expected to drive the growth of the Global Focused Ultrasound System Industry. The performance evaluation of the focused ultrasound system for the treatment of different diseases is further expected to drive the growth of the Global Focused Ultrasound System Industry shortly. Whereas, low product penetration in middle and low-income countries may hamper the potential growth prospect of the focused ultrasound system market.

Focused Ultrasound System Industry: Regional Outlook

The global market is expected to be North America due to high product penetration and a high number of procedures. Europe is expected to be the second most lucrative focused ultrasound system market due to higher patient preference for non-invasive treatment. Latin America’s Global Focused Ultrasound System Industry is expected to experience steady growth due to the increasing number of procedures using focused ultrasound systems. Asia-Pacific is expected to be the fastest-growing focused ultrasound system market due to rapidly improving healthcare infrastructure in countries such as India and China. The Middle East and Africa are expected to be the least lucrative Global Focused Ultrasound System Industry due to low product penetration and lack of proper healthcare infrastructure in the majority of the region.

Global Focused Ultrasound System Industry: Key Players

The key players operating in the global market are: ALPINION MEDICAL SYSTEMS Co., Ltd., INSIGHTEC Ltd., Sonacare Medical, GENERAL ELECTRIC COMPANY, Siemens Ltd., Haifu Medical Technology Co., Ltd., FUS Instruments, MEDSONIC LTD, Mirabilis Medical, Inc., EDAP, and others

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.

Ask The Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-8582

The report covers exhaust analysis on:

Focused Ultrasound System Market Segments
Focused Ultrasound System Market Dynamics
Focused Ultrasound System Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition and companies involved
Indication
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, UK, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Focused Ultrasound System Industry: Segmentation

By technology

MR-Guided

By application

Oncology
Neurosurgery
Urology
Cosmetics
Other

By end user

Hospitals
Specialty Clinics
Laboratories

Report Highlights:

Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/8582

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Global Pelvic Cancer Induced Hemorrhegic Cystitis Market Continues Upward Trajectory, Projected to Reach US$11 Billion 18.01% value CAGR by 2033

The global pelvic cancer induced hemorrhagic cystitis market is expected to experience significant growth in the coming decade, reaching a staggering US$11 billion by 2033. This represents a compound annual growth rate (CAGR) of 18.01% from a valuation of US$2.1 billion in 2023, according to a recent market analysis.

Hemorrhagic cystitis is a debilitating condition that causes inflammation and bleeding in the bladder. It can be a side effect of various treatments for pelvic cancer, including radiation therapy and chemotherapy. The increasing prevalence of pelvic cancer, coupled with growing awareness of hemorrhagic cystitis, is a major driver of market growth.

The market demand is being driven by a growing population awareness of early diagnosis and treatment for associated ailments, as well as a constant shift towards unhealthy diets and sedentary lifestyles. Drug research advancements have made it possible for doctors to inject medications directly into sick tissues without endangering nearby healthy tissues. This has increased patient compliance, which is predicted to fuel market expansion.

Obtain Your Sample Report Copy:
https://www.futuremarketinsights.com/reports/sample/rep-gb-16245

The high research and development cost associated with the manufacturing of hemorrahagic cystitis treatment drugs, coupled with increased penetration of generic drugs, is likely to restrain market growth. However, technological advancements in drug development to manufacturing cost-effective and side-effect-free drugs are anticipated to create opportunities for industry movements. Moreover, the use of High approval rate of Ifosfamide and cyclophosphamide for use in a variety of malignancies, both in children and adults are driving the market for Haemorrhagic Cystitis. North America dominates the market for Pelvic Cancer induced Hemorrhagic Cystitis with market valuation of US$ 3.6 Billion, followed by APAC.

Key Takeaways

North American Pelvic cancer induced hemorrhegic cystitis market is expected to reach US$ 3.6 Billion with a CAGR of 14.87% during the forecast period.
With a CAGR of 15.1%, APAC is projected to be fastest growing market for this haemorrhagic cystitis.
By treatment type, chemotherapy is expected to dominate the market with a 2/3^rd segment share.
Radiation therapy is anticipated to be a secondary treatment for hemorrhegic cystitis after Chemotherapy.
High cost of treatments and side-effects in post-treatment period will restrict market growth.
Adoption of combination therapies and novel therapies are expected to proliferate product demand.
Technological advancements in drug development for treatment of pelvic induced hemorrhagic cystitis is anticipated to strengthen market footprint.

Get Familiar With Our Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16245

Competitive Landscape

Key players in the Pelvic cancer induced hemorrhagic Cystitis Market are: Johnson & Johnson Services, Inc, Astellas Pharma Inc, Eli Lilly and Company, Sanofi, Ipsen Pharma, Bayer AG, AstraZeneca, Valeant Pharmaceuticals International, Inc., Merck & Co., Inc., Pfizer Inc.

In April 2022, Pfizer made an equity investment worth USD 25 million in Zentalis Pharmaceuticals, Inc. This investment is expected to help Pfizer to leverage its development capabilities globally
In May 2022, Pfizer entered a research collaboration agreement of two years with NetVation DL Medicine. This collaboration is anticipated to aid and advance Pfizer in its research activities
In June 2022, Roche introduced a human papillomavirus (HPV) self-sampling solution that enables patients to perform HPV screening in the presence of a healthcare worker. This is expected to expand the company’s cancer screening solution line-up
In June 2022, Valencia Technologies Corporation announced the implantable neuromodulation technology product eCoin®, which is reshaping the delivery of long-term therapy for bladder control, is a tibial implant for Urge Urinary Incontinence (UUI). eCoin® received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) in March 2022, making it the first and only FDA-approved implantable tibial neurostimulator indicated for the treatment of urge urinary incontinence (UUI). This new product has helped the company to increase its portfolio.

Unlock In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/16245

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the Bullous Keratopathy market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023 to 2033.

Key Segments Profiled in the Pelvic Cancer Induced Hemorrhagic Cystitis Market Industry Survey

By Treatment:

Bone Marrow Transplant
Chemotherapy
- Cyclophosphamide
- Ifosfamide
Radiation Therapy
Other Treatments

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Ovulation Microscope Industry is projected to develop at an excellent 11.2% CAGR and reach a profitable US$ 158.6 Million by 2033 | As Per FMI Expert

The Global Ovulation Microscope Industry is on the cusp of a remarkable surge, fueled by a growing demand for at-home fertility analysis solutions. According to Future Market Insights (FMI), the market is projected to register an impressive Compound Annual Growth Rate (CAGR) of 11.2% from 2023 to 2033.

This thriving market, valued at US$48.9 million in 2022, is anticipated to reach US$54.9 million in 2023 and is poised for significant further expansion. This growth is attributed to the increasing popularity of self-managed fertility tracking and the convenience offered by ovulation microscopes.

The phenomenal expansion of the Global Ovulation Microscope Industry can be ascribed to increased knowledge of fertility tracking and a focus on personalized healthcare. Demand for ovulation microscopes is expected to skyrocket as more people choose proactive ways of family planning.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-8598

The development of point-of-care ovulation detection tools like the ovulation microscope will spur market expansion. If the person ovulates, a drop of saliva placed on the microscope’s lens will exhibit a pattern resembling a ferning crystal.

Ovulation microscopes are simple to use and trustworthy tools for predicting the days leading up to the fertile window. Future demand for these devices will rise with the development of less expensive, reusable, and single-use ovulation tests. The use of an ovulation microscope will be advantageous because the average age of first-time mothers is rising and reproductive issues are becoming more prevalent.

The Centers for Disease Control and Prevention estimate that 10% of American women (6.1 million) between the ages of 15 and 44 have trouble getting pregnant.

Global Ovulation Microscope Industry: Dynamics

The development of devices that as easy to use and used in home care settings along with the lower cost of devices will increase the demand for ovulation microscopes in the forecast period. Increasing general awareness in developed regions and developing regions will significantly boost the Global Ovulation Microscope Industry shortly.

The launch of new products with new advanced technology will further spur the Global Ovulation Microscope Industry. Identification of a wider fertile window creates more opportunities for the ovulation microscope market to grow shortly. Despite the increasing knowledge of the genetic causes of fertility, advancement in the diagnosis and treatment have remained relatively stagnant which might hamper the Global Ovulation Microscope Industry growth shortly.

Ask from The Market Research Expert
https://www.futuremarketinsights.com/ask-question/rep-gb-8598

Global Ovulation Microscope Industry: Overview

Increasing focus on the development of new devices and treatment methods to increase the pregnancy rate with infertility disorder will drive the market growth of ovulation microscopes in the forecast period. The increasing prevalence of disorders related to pregnancy and increasing awareness programs will increase the demand for saliva-based ovulation microscopes.

Increasing demand for point-of-care testing and relatively low cost will significantly boost the Global Ovulation Microscope Industry in the forecast period. The growing potential of point-of-care testing to improve healthcare in developing and developed regions will grow the market shortly.

Ovulation Microscope Industry: Region-wise Outlook

Based on geography, the Global Ovulation Microscope Industry is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa.

The North American market for Ovulation Microscope holds the largest revenue share, due to more number of key players and new players entering into Global Ovulation Microscope Industry along with the increasing cases of infertility and growing awareness.

Europe accounts for the second largest revenue share in the Global Ovulation Microscope Industry, owing to the increasing development of technologically advanced products and the rising adoption of ovulation microscopes. Asia Pacific is expected to witness rapid growth in the ovulation microscope market, owing to the growing rate of infertility and rising demand for fast and independent tests with accuracy in developing countries such as India.

China is expected to register significant growth in the Global Ovulation Microscope Industry, due to the presence of local players in point-of-care testing products markets. Latin America and the Middle East & Africa are projected to exhibit slow growth in the Ovulation Microscope market, owing to a lack of R&D labs and slow adoption of new technology.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-8598

Global Ovulation Microscope Industry: Key Players

Examples of some of the key manufacturers present in the Global Ovulation Microscope Industry are Geratherm Medical AG, Fairhaven Health, LLC, Dual Core B.V., and Hangzhou Sejoy Electronics & Instrument Co. Ltd., among others.

Regional analysis includes

North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa

Global Ovulation Microscope Industry: Segmentation

Segmentation by Distribution Channel

Hospitals pharmacies
Retail Pharmacies
Drug Stores
E-Commerce

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

RFID Readers Market is Booming Across the Globe and Witness Huge Growth by Key Players to 2027

“Radio Frequency Identification (RFID) Readers Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” is the title of a recent research study released by Future Market Insights (FMI). According to the survey, customers are being encouraged to use RFID technology by the rising ubiquity of modern technology and the complexity of supply chains. As a result, companies in the RFID reader industry are constantly expanding their product lines to satisfy the needs of customers everywhere.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6432

According to the report, the global RFID readers market is expected to witness a significant CAGR of 12.3% from 2017 to 2027. The market was worth US$ 5545.5 Mn in 2017 and is expected to rise to a valuation of US$ 17,758.8 Mn by the end of the forecast period.

Retail Sector to Intensify its Deployment of RFID Technology

Growing demand for efficient supply chain operations in the retail sector is leading to a rising demand for RFID technology. RFID tags and readers are installed by companies as a part of their security issues to prevent risk of theft and loss. Companies are intensifying the adoption of automated item identification systems for supply chain management in order to improve inventory allocation efficiencies. The growing need for efficient supply chain management is expected to support revenue growth of the RFID readers market during the forecast period. RFIDs store detailed information up to 2 KB related to the product on which it is tagged. Prices and details of the product with RFID tags are spontaneously chronicled when the customer approaches the counter, without scanning each and every product, which saves time of the customer. Furthermore, it permits cost tally in one scan, which saves time of the user as well as the product retailer.

Breech and Data Insecurity to Hinder Market Growth in the Long Run

RFID readers and tags do not have a locking system or for that matter, a secure password. As a result, the risk of information breach increases. The dearth of security systems is a restraining factor in the growth of the RFID readers market. Several companies in the healthcare and other industries avoid using these systems for asset tracking as there is a chance of information breach related to the usage of medicine.

With this factor restraining the growth of the market, it is yet to be seen where the global RFID readers market will stand in the next 10 years.

Request for Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6432

Market Taxonomy

Types

Fixed RFID Readers
Integrated RFID Readers
Non-Integrated RFID Readers
Handheld RFID Readers

Frequency

Low Frequency (125 kHz, 134.2 kHz)
High Frequency (13.56 MHz)
Ultra High Frequency (865- 928 MHz)

Communication

Wi-Fi
Ethernet
Others (Bluetooth)

Industry

Logistics and
Transportation
Aerospace and
Defense
Automotive
Retail
Agriculture
Healthcare
Government

Region

North America
Latin America
Western Europe
Eastern Europe
MEA
Asia Pacific
China
Japan

Request for Customization:
https://www.futuremarketinsights.com/customization-available/rep-gb-6432

Author:

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Tunable Filter Market Thrives with 7.4% Value CAGR, Manufacturers Lead Surge to US$ 159 Mn by 2027

The global tunable filter market is anticipated to grow at a quick rate during the assessment period, according to a recent analysis by Future Market Insights titled “Tunable Filter Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017–2027)”. The study report addresses several factors that support its expansion in addition to a few that work against it. This thorough research report covers trends, risks, opportunities, growth drivers, challenges, and their implications on the global tunable filter market.

Detailed pricing analysis of different tunable filters across key regions is also discussed in the research study. The segmental analysis across North America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Latin America, Japan and Middle East and Africa (MEA) is carried out which is used to track the future projections for a period of ten years, pertaining to value of the global tunable filter market.

To Get a Sample Copy of the Report Visit:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6130

Global Tunable Filter Market: Factors Impacting Growth

There are several factors that have a positive influence on the growth of the tunable filter market. The increasing spending in defence has spurred the use of tunable filters in vehicular radios, wireless communication equipment and radars thus actively contributing to the growth of the global tunable filter market.

Moreover, growing wireless sector is expected to drive the growth of tunable filter market. Also, the emergence of 5G is expected to contribute to the market’s growth. Tunable filters are used in 5G networks and have a crucial role of ensuring proper functioning of 5G technology-based communication systems. However, limited commercial availability of some tuneable filters (for instance, BST or Barium Strontium Titnate) is expected to hinder the growth of the global tunable filter market.

Global Tunable Filter Market: Segmental Snapshot

The global tunable filter market is segmented on the basis of application and region.

In the application category, the wireless communication equipment segment is the largest thus leading the global market. This segment reflected high growth rate owing to increased adoption of tunable filters in wireless communication equipment

With respect to region, North America is expected to present high growth opportunities for tunable filters. in addition, the Asia Pacific excluding Japan (APEJ) region is also highly lucrative and the tunable filter market in this region is projected to grow at a high rate during the forecast period.

Global Tunable Filter Market: Competitive Assessment

This exhaustive research contains detailed intelligence on various players involved in the manufacturing and distribution of tunable filters. Prominent players include Analog Devices Inc., RS Microwave Co Inc., K&L Microwave, Inc., Fairview Microwave Inc., I2R Nanowave Inc., Pole/Zero Corporation and Atlanta Micro, Inc.

Request for Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6130

Market Segmentation

By Application:

Tactical Radios
Avionics and Shipboard Cosite Mitigation
Military Vehicular Mount Radio Components
Wireless Communication Equipment

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
Middle East and Africa

Author:

About Future Market Insights (FMI)

Contact Us:

Nandini Singh Sawlani

Global Formulation Development Outsourcing Industry is anticipated to grow at a robust 7.2% CAGR to reach an unprecedented US$66.60 Billion milestone by 2032 | FMI

The Global Formulation Development Outsourcing Industry is on a trajectory for impressive growth, with projections indicating a surge to a staggering US$66.60 billion by 2032. This significant rise represents a substantial leap from the US$33.23 billion recorded in 2022. Fueling this remarkable growth is a robust Compound Annual Growth Rate (CAGR) of 7.2%, signifying a vibrant and dynamic market poised for significant expansion between 2022 and 2032.

The pharmaceutical industry’s increasing spending on research and development is one of the main factors causing this extraordinary upsurge. Formulation Development Outsourcing services are becoming more and more popular among small and medium-sized pharmaceutical enterprises as they realize

the necessity for specialized skills and sophisticated knowledge.

Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-15131

Increases in pharmaceutical and raw material costs, as well as demand, can have a major negative impact on the market value of Formulation Development Outsourcing. As a marketing tactic to boost market growth, the Formulation Development Outsourcing company developed medical drug patent protection expiration.

Because of the increasing number of biopharmaceutical and pharmaceutical businesses outsourcing their work, the Formulation Development Outsourcing market has grown significantly. In 2021, the market for Formulation Development Outsourcing in North America maintained a commanding 26.8% share.

For instance, numerous clinical trials are conducted in the United States. Furthermore, it is anticipated that Europe will hold a significant share of the Formulation Development Outsourcing industry. This is due to the government’s supportive initiatives, sedentary lifestyles, and the rise in chronic illnesses driving the market in this region.

Global Formulation Development Outsourcing Industry Key Takeaways

With a market share of US$ 66.6 billion, the Formulation Development Outsourcing industry is predicted to grow at a 7.2% CAGR through 2032.
The Formulation Development Outsourcing market in North America is anticipated to be valued at US$22.8 billion in 2021.
Through 2032, the Asia Pacific Formulation Development Outsourcing industry is predicted to grow at an 8.1% CAGR.
The Formulation Development Outsourcing industry is expected to be worth US$ 31 billion in 2021.
The oral segment of the Formulation Development Outsourcing industry held a 63.6% revenue share in 2021.
Based on services, the formulation development segment of the Formulation Development Outsourcing industry had a revenue share of 76.6% in 2021.

Ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-15131

Competitive Landscape from the Global Formulation Development Outsourcing Industry:

Some of the primary measures players are employing to take advantage of the Formulation Development Outsourcing industry opportunities include frequent product launches, geographic expansions, and distribution agreements to expand their consumer base.

Global Formulation Development Outsourcing Industry Key Players

SGS S.A.
Intertek Group plc
Recipharm
Lonza
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Element
Labcorp
Thermo Fisher Scientific, Inc. (Patheon)
Catalent Inc.

Recent Developments in the Global Formulation Development Outsourcing Industry:

Intertek extended its pharmaceutical services laboratory in Melbourne in 2019.
Cataleny Inc. announced in 2021 that it has acquired the packaging and production businesses of Acorda Therapeutics Inc.
In addition, Quotient BioSciences announced plans to acquire Arcinova, a UK-based startup, in 2021. As a result of this acquisition, Quotient Bioscience is now able to offer new services such as medical goods, clinical testing, and drug substance synthesis.
In 2020, Catalent Inc. announced the acquisition of MaStherCell Global Inc. As a result of this increase, the biotech sector is fortifying its position, and new avenues for gene therapy are emerging.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/15131

Want More Insights:

In North America, the Drug Development Outsourcing Market is dominated by the United States due to the presence of a large number of pharmaceutical and biotechnology companies, the availability of skilled professionals, and the presence of a well-established healthcare infrastructure. Canada is also expected to witness significant growth in the market due to the increasing adoption of outsourcing by pharmaceutical and biotechnology companies.

Global Formulation Development Outsourcing Industry Key Segments

By Service:

Preformulation
Formulation Development

By Formulation:

Oral
Injectable

By Therapeutic Area:

Oncology
Infectious Diseases
Neurology
Hematology
Respiratory
Cardiovascular
Dermatology
Others

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani